Altered spacing of promoter elements due to the dodecamer repeat expansion contributes to reduced expression of the cystatin B gene in EPM1.

Progressive myoclonus epilepsy of the Unverricht-Lundborg type (EPM1; MIM 254800) is an autosomal recessive disorder characterized by seizures, myoclonus and progression to cerebellar ataxia. EPM1 arises due to mutations in the cystatin B (CSTB) gene which encodes a cysteine proteinase inhibitor. Only a minority of EPM1 alleles carry point mutations, while the majority contain large expansions of the dodecamer CCCCGCCCCGCG repeat which is present at two to three copies in normal individuals. The dodecamer repeat is located in the 5' flanking region of the CSTB gene, presumably in its promoter. The pathological repeat expansion results in a reduction in CSTB mRNA, which may be cell specific. To elucidate the mechanism of this reduction of gene expression, we have studied the putative CSTB promoter in vitro. A 3.8 kb fragment, containing the putative promoter with a 600 bp repeat expansion, showed a 2- to 4-fold reduction in luciferase activity compared with an identical fragment with a normal repeat; this reduction was observed only in certain cell types. Introduction of heterologous DNA fragments of 730 and 1000 bp into the normal promoter, instead of the repeat expansion, showed similarly reduced activity. Terminal deletions of the promoter implicate a putative AP-1 binding site, upstream of the repeat, in CSTB transcription activation. We propose that a novel mechanism of pathogenesis, the altering of the spacing of transcription factor binding sites from each other and/or the transcription initiation site due to repeat expansion, is among the causes of reduction in CSTB expression and thus EPM1.

[1]  Len A. Pennacchio,et al.  Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice , 1998, Nature Genetics.

[2]  J. Waltho,et al.  The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L. , 1998, Biochemistry.

[3]  S. Antonarakis,et al.  A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset. , 1998, American journal of human genetics.

[4]  Alain Malafosse,et al.  Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy , 1997, Nature.

[5]  Len A. Pennacchio,et al.  Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1 , 1997, Nature Genetics.

[6]  E. Zandi,et al.  AP-1 function and regulation. , 1997, Current opinion in cell biology.

[7]  J. Rommens,et al.  Unstable insertion in the 5′ flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1 , 1997, Nature Genetics.

[8]  M C Peitsch,et al.  Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1). , 1997, American journal of human genetics.

[9]  S. Burley,et al.  RNA polymerase II transcription initiation: a structural view. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Myers,et al.  Isolation and characterization of the mouse cystatin B gene. , 1996, Genome research.

[11]  S. Wölfl,et al.  Transcription of the human corticotropin-releasing hormone gene in NPLC cells is correlated with Z-DNA formation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Len A. Pennacchio,et al.  Mutations in the Gene Encoding Cystatin B in Progressive Myoclonus Epilepsy (EPM1) , 1996, Science.

[13]  K. Struhl,et al.  Chromatin Structure and RNA Polymerase II Connection: Implications for Transcription , 1996, Cell.

[14]  R. Durbin,et al.  A dot-matrix program with dynamic threshold control suited for genomic DNA and protein sequence analysis. , 1995, Gene.

[15]  K. Davies,et al.  Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation , 1993, Cell.

[16]  Y. Uchiyama,et al.  Structural organization of the gene encoding rat cystatin beta. , 1992, Gene.

[17]  J. Mandel,et al.  Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome , 1991, Science.

[18]  D. Lipman,et al.  Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Barrett,et al.  Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. , 1987, The Journal of biological chemistry.

[20]  P. Moorhead,et al.  Establishment and characterization of human neuroblastoma cell lines. , 1976, Cancer research.

[21]  T. Heinemeyer,et al.  Databases on transcriptional regulation : TRANSFAC , TRRD and COMPEL , 1997 .

[22]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[23]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[24]  K. Osoegawa,et al.  Cosmid assembly and anchoring to human chromosome 21. , 1995, Genomics.

[25]  W. Pearson Rapid and sensitive sequence comparison with FASTP and FASTA. , 1990, Methods in enzymology.

[26]  R A Ross,et al.  Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. , 1989, Cancer research.